Nkarta (NKTX) Competitors

Nkarta (NASDAQ:NKTX) and Immatics (NASDAQ:IMTX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, community ranking, valuation, dividends, risk and institutional ownership.

Does the MarketBeat Community prefer NKTX or IMTX?

Nkarta received 33 more outperform votes than Immatics when rated by MarketBeat users. Likewise, 78.05% of users gave Nkarta an outperform vote while only 75.61% of users gave Immatics an outperform vote.

Company	Underperform	Outperform
Nkarta	Outperform Votes 64 78.05%	Underperform Votes 18 21.95%
Immatics	Outperform Votes 31 75.61%	Underperform Votes 10 24.39%

Which has preferable earnings and valuation, NKTX or IMTX?

Immatics has higher revenue and earnings than Nkarta. Nkarta is trading at a lower price-to-earnings ratio than Immatics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nkarta	N/A	N/A	-$117.50M	-$1.66	-1.05
Immatics	$155.84M	3.21	-$104.98M	$0.14	29.36

Is NKTX or IMTX more profitable?

Nkarta has a net margin of 0.00% compared to Immatics' net margin of -47.94%. Immatics' return on equity of -15.90% beat Nkarta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nkarta	N/A	-27.13%	-21.67%
Immatics	-47.94%	-15.90%	-9.38%

Which has more volatility and risk, NKTX or IMTX?

Nkarta has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, Immatics has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

Do analysts prefer NKTX or IMTX?

Nkarta presently has a consensus target price of $14.86, indicating a potential upside of 748.98%. Immatics has a consensus target price of $16.67, indicating a potential upside of 305.52%. Given Nkarta's stronger consensus rating and higher probable upside, research analysts clearly believe Nkarta is more favorable than Immatics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nkarta	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25
Immatics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Do insiders and institutionals have more ownership in NKTX or IMTX?

80.5% of Nkarta shares are held by institutional investors. Comparatively, 64.4% of Immatics shares are held by institutional investors. 8.7% of Nkarta shares are held by company insiders. Comparatively, 3.3% of Immatics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Does the media favor NKTX or IMTX?

In the previous week, Immatics had 2 more articles in the media than Nkarta. MarketBeat recorded 4 mentions for Immatics and 2 mentions for Nkarta. Immatics' average media sentiment score of 1.33 beat Nkarta's score of 0.71 indicating that Immatics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nkarta	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Immatics	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Nkarta beats Immatics on 10 of the 18 factors compared between the two stocks.